Relationship Between Dyslipidemia and The Response of Diabetic Macular Edema to Intravitreal Injection of Anti Vascular Endothelial Growth Factor Agents
Condition(s):Diabetic Macular EdemaLast Updated:January 16, 2024Recruiting
Include Studies Not Open or Pending
Condition(s):Diabetic Macular EdemaLast Updated:January 16, 2024Recruiting
Condition(s):Choroidal NeovascularizationLast Updated:February 7, 2024Not yet recruiting
Condition(s):Diabetic Macular Edema; Age-Related Macular Degeneration; Choroidal Neovascularization; Myopic Choroidal Neovascularisation; Diabetic RetinopathyLast Updated:August 10, 2022Recruiting
Condition(s):IrisLast Updated:August 2, 2022Not yet recruiting
Condition(s):Diabetic Macular EdemaLast Updated:February 20, 2024Recruiting
Condition(s):Macular Edema Due to Type 2 Diabetes MellitusLast Updated:March 8, 2023Recruiting
Condition(s):Neovascular Age-related Macular Degeneration(nAMD)Last Updated:November 13, 2023Recruiting
Condition(s):Ocular MelanomaLast Updated:October 30, 2023Recruiting
Condition(s):Diabetic Retinopathy; Diabetic Macular Edema; Anti-vascular Endothelial Growth FactorLast Updated:February 22, 2024Not yet recruiting
Condition(s):Advanced Solid Tumor CancerLast Updated:January 31, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.